QuickView for ECT2;jsessionid=73E0DCC8DB7E8C5F35100216092D1728;jsessionid=F3EE8195C6D4F1163722893B1ED6D721;jsessionid=E6D8D187EEF8DF6FBA385379B0FF65F7 (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Colon mucosa
Hematopoietic stem cell of bone marrow
Ileum mucosa
Basophil of peripheral blood
Thymus gland

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Injury of liver
Liver regeneration
Microbial culture finding
Severe combined immunodeficiency disease
Social environment related disease

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

Spiperone
cefprozil
Zimeldine
Pyrogallol
Disopyramide

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

SV40_large_T_Ag_specific-S
RHO
CITED1
CSTB
MIR585

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Gr…
Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic canc…
The dynamic behavior of Ect2 in response to DNA damage.
Re-enforcing hypoxia-induced polyploid cardiomyocytes enter cytokinesis through activation of β-cate…
ECT2 promotes malignant phenotypes through the activation of the AKT/mTOR pathway and cisplatin resi…

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for ECT2;jsessionid=73E0DCC8DB7E8C5F35100216092D1728;jsessionid=F3EE8195C6D4F1163722893B1ED6D721;jsessionid=E6D8D187EEF8DF6FBA385379B0FF65F7

Explore Clinical Trials Results